Opening lecture

Robin OFFORD

Geneva University Medical School, Switzerland

“Improving on nature: therapeutic enhancement of polypeptides”

Plenary lectures

Paul ALEWOOD	University of Queensland, Australia	“Drugs from Venoms”
George CHANDY	University of California Irvine, USA	“Ion Channels in lymphocytes : therapeutic targets for autoimmune diseases”
Richard DIMARCHI	Indiana University, USA	“The Emergence of Chemical Biotechnology as a Means to Optimal Protein-Based Medicines”
Tomas GANZ	David Geffen School of Medicine at UCLA, USA	“Hepcidin, a new iron-regulatory and host-defense hormone”
Bob HANCOCK	University of British Columbia, Vancouver, Canada	“Cationic host defence peptides as antibiotics and modulators of innate immunity”
Peter HOFFMANN	Genzyme Pharmaceuticals, USA	“As Hannibal Delivered Elephants Across the Alps : Genzyme Delivers Peptides and Proteins Across the Blood Brain Barrier”
André MÉNEZ	CEA-Saclay, France	“From Toxins to Drugs”
Stephen SCHNEIDER	Trimeris, USA	"Development of the HIV Fusion Inhibitors Fuzeon and T-1249"

Contributed lectures

José DE CHASTONAY

Bachem, USA

“The outlook for peptide drugs and the intricate relationship between the API manufacturers and their sponsors”